ADMA Biologics, Inc. (ADMA)
16.11
-0.21
(-1.29%)
USD |
NASDAQ |
Feb 20, 15:08
ADMA Biologics Price : 16.11 for Feb. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arcutis Biotherapeutics, Inc. | 25.83 |
| Marker Therapeutics, Inc. | 1.44 |
| CorMedix, Inc. | 7.02 |
| Viridian Therapeutics, Inc. | 27.50 |
| Editas Medicine, Inc. | 1.78 |
Price Related Metrics
| PE Ratio | 18.92 |
| PS Ratio | 8.110 |
| PEG Ratio | 0.0909 |
| Price to Book Value | 8.892 |
| Price to Free Cash Flow | 97.58 |
| Earnings Yield | 5.29% |
| Market Cap | 3.834B |
| PEGY Ratio | 0.0909 |
| Operating PE Ratio | 23.73 |
| Normalized PE Ratio | 18.63 |